Pretreatment hemoglobin, myeloma subtype, and induction regimens as independent prognostic factors for survival after autologous stem cell transplantation in multiple myeloma: A retrospective cohort study
{{output}}
Background: Autologous hematopoietic stem cell transplantation (auto-HSCT) is a standard of care for eligible patients with multiple myeloma (MM). However, outcomes vary significantly. While cytogenetics and the International Sta... ...
